StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Interpace Biosciences's price to sales ratio was 3.8× on Oct 19, 2026, against 0.1× a year earlier. Over the last 2 years it ranged from 0.1× to 5.8×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20263.8×+3.7
2025Dec 31, 20250.1×−0.1
2024Dec 31, 20240.3×–

More Interpace Biosciences figures

See a number that looks wrong?